Abstract B35: The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts

Abstract

Abstract This abstract is being presented as a short talk. A full abstract is printed in the Proffered Abstracts section (PR07) of the Conference Proceedings. Citation Format: Lee A. Albacker, Rainer Kohler, Ralph Weissleder, Peter K. Sorger. The strength of drug selection determines the maximum fitness cost of resistance mutations in culture and xenografts. [abstract]. In: Proceedings of the AACR Precision Medicine Series: Drug Sensitivity and Resistance: Improving Cancer Therapy; Jun 18-21, 2014; Orlando, FL. Philadelphia (PA): AACR; Clin Cancer Res 2015;21(4 Suppl): Abstract nr B35.